Xeomin® 100U Neurotoxin Solution
Merz Pharmaceuticals’ Xeomin 100U contains purified botulinum toxin type A (99.5% neurotoxin protein) without complexing proteins. FDA-approved for cosmetic and therapeutic use, it demonstrates 94% patient satisfaction in clinical trials for glabellar lines reduction. Requires professional administration by licensed practitioners.
Key Advantages:
• Additive-free formulation
• 3-4 day onset period
• 3-6 month duration
• 0.1% resistance rate
Clinical Applications:
• Dynamic facial rhytids
• Chronic migraine prophylaxis
• Severe primary axillary hyperhidrosis
• Neurogenic detrusor overactivity
Mechanism of Action:
• Selective neuromuscular blockade
• Inhibits acetylcholine release
• Temporary chemodenervation (3-6 months)
• Presynaptic SNARE protein cleavage
Pharmaceutical Specifications:
🧪 Lyophilized powder formulation
⚖️ 100 unit dosage strength
🌡️ Store at 2-8°C (35-46°F)
Administration Protocol:
1. Reconstitute with 0.9% sodium chloride
2. Use within 24 hours post-reconstitution
3. Intramuscular injection technique required
4. Follow anatomical injection mapping
5. Maximum dose: 50U per treatment area
Medical Disclaimer: Xeomin® must be administered by qualified healthcare professionals. Individual results may vary based on muscle mass, injection technique, and metabolic factors. Contraindicated in patients with neuromuscular disorders or hypersensitivity to botulinum toxins. Full prescribing information available upon request.
Margaret Turner –
At 58, I don’t mess around with gimmicks. Xeomin’s been my go-to for crow’s feet since 2019. Why? No fancy proteins—just the pure toxin. My esthetician says that means less risk of building resistance, and I’ve never had it ‘stop working.’ It’s subtle—people say I look rested, not frozen. Starts working faster than Dysport for me.